Quantcast

Latest Ribbon symbolism Stories

2014-06-30 08:30:19

BALTIMORE, June 30, 2014 /PRNewswire/ -- Goldman Small Cap Research, a stock market research firm focused on the small cap and micro cap sectors, announced today that it has released a new research report on MetaStat, Inc. (OTCQB: MTST). The life sciences company develops and commercializes diagnostic products and novel therapeutics for the early and reliable prediction and treatment of systemic metastasis, the process by which cancer spreads from a primary tumor through the...

2014-06-27 23:08:47

Montclair Breast Center’s own Patient Outcomes Results support study that finds 3D Mammography is more effective in finding breast cancer than 2D mammography. (PRWEB) June 27, 2014 3D Mammography (tomosynthesis), a 3-dimensional breast imaging technique, plays a key role in breast cancer detection at the most treatable stages. Dr. Nancy Elliott, a renowned breast surgeon and Founder and Director of Montclair Breast Center, a New Jersey Breast Center of Excellence, says; “Within six...

2014-06-26 08:29:08

Two-stage Financing will Support Expansion of Commercial Rollout of MarginProbe CAESAREA, Israel, June 26, 2014 /PRNewswire/ -- Dune Medical Devices, announced today that it has successfully completed the first of a two stage $21 million equity financing. The initial closing was completed for $14 million with a second tranche of $7 million to be completed by October 2014. Following the successful launch of MarginProbe, this financing provides the necessary resources to expand the...

2014-06-26 08:27:43

- Trial will measure investigational compound's efficacy and safety in patients with HER2-negative breast cancer, associated with BRCA 1, BRCA 2 mutations NORTH CHICAGO, Ill., June 26, 2014 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the initiation of a Phase III clinical trial evaluating the safety and efficacy of its investigational compound, veliparib (ABT-888), when added to carboplatin and paclitaxel, two chemotherapeutic medicines, in patients with advanced breast...

2014-06-25 23:14:27

AllMed webinar provides in-depth review of the latest in standard of care for the genetic testing of breast and ovarian cancer. Portland, Oregon (PRWEB) June 25, 2014 Advances in genetic testing technology have improved detection rates for BRCA1 and BRCA2 mutations in individuals who are at high risk for breast and ovarian cancer, but some mutations are missed with standard genetic testing. During a recent AllMed webinar, Dr. Della Howell, board-certified hematologist-oncologist,...

2014-06-25 23:07:59

The Jacqueline M. Wilentz Comprehensive Breast Center Honored for Providing Exceptional Patient Care and Treatment Long Branch, NJ (PRWEB) June 25, 2014 The Jacqueline M. Wilentz Comprehensive Breast Center at Monmouth Medical Center has been named a recipient of the Women’s Choice Award as one of America’s Best Breast Centers, acknowledging its dedication to providing exceptional patient care and treatment. Breast cancer is the second most common form of cancer among American women...

2014-06-25 16:26:04

DUBLIN, June 25, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/s3w5dh/breast_imaging) has announced the addition of the "2014 Report on the International Breast Imaging (Mammography, Breast MRI, Breast Ultrasound, Tomosynthesis, Nuclear Imaging) Market - Forecast to 2019" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 This report covers the market analysis for various imaging technologies used for breast tissue imaging....

2014-06-24 20:21:36

Study using Hologic 3D Mammography systems is the largest to date involving 139 doctors from 13 U.S. academic and community-based sites BEDFORD, Mass., June 24, 2014 /PRNewswire/ -- Hologic, Inc. (NASDAQ: HOLX) today announced that a groundbreaking study published in the June 25, 2014 issue of the Journal of the American Medical Association (JAMA), found that Hologic's 3D Mammography (breast tomosynthesis) screening technology finds significantly more invasive cancers than a traditional...

2014-06-24 11:18:40

Penn State A virus not known to cause disease kills triple-negative breast cancer cells and killed tumors grown from these cells in mice, according to Penn State College of Medicine researchers. Understanding how the virus kills cancer may lead to new treatments for breast cancer. Adeno-associated virus type 2 (AAV2) infects humans but is not known to cause sickness. In prior studies, the researchers tested the virus on a variety of breast cancers that represent degrees of...

2014-06-23 23:07:48

Local New York based agency is excited to offer $1 for every quote issued in July towards Stupid Dumb Breast Cancer in honor of Cancer Survivor Month. New York, NY (PRWEB) June 23, 2014 New York insurance agency, Schmutter, Strull, Fleisch, Inc. is excited to announce the launch of Cancer Survivor Month. National Cancer Survivor Day takes place June 1st, Schmutter, Strull, Fleisch, Inc. has dedicated the month of June to celebrating cancer survivors and raising money for a local cancer...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related